| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.031 | 0.3 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.03 | 0.3 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |